Tissue plasminogen activator‐mediated PDGF signaling and neurovascular coupling in stroke

Summary.  The use of tissue plasminogen activator (tPA) as a thrombolytic treatment in ischemic stroke is limited largely due to concerns for hemorrhagic complications. The underlying mechanisms are still unknown, but evidence is beginning to emerge that tPA interacts with key regulators of the neurovascular unit (NVU), and that these interactions may contribute to the undesirable side effects associated with the use of tPA in ischemic stroke. Understanding these connections and tPA’s normal function within the NVU may offer new insights into future therapeutic approaches.

[1]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[2]  T. Takano,et al.  Astrocyte-mediated control of cerebral blood flow , 2006, Nature Neuroscience.

[3]  C. Iadecola.  Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[4]  M. Cipolla,et al.  Postischemic attenuation of cerebral artery reactivity is increased in the presence of tissue plasminogen activator. , 2000, Stroke.

[5]  M. Fini,et al.  Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94 , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[6]  José A Fernández,et al.  Activated protein C inhibits tissue plasminogen activator–induced brain hemorrhage , 2006, Nature Medicine.

[7]  T. Coleman,et al.  HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY Neuroserpin reduces cerebral infarct volume and protects neurons from , 2022 .

[8]  S. Tsirka,et al.  Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice , 2006, Journal of Cell Science.

[9]  C. Iadecola,et al.  Key role of tissue plasminogen activator in neurovascular coupling , 2008, Proceedings of the National Academy of Sciences.

[10]  T. Coleman,et al.  Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. , 2000, Blood.

[11]  Z. Mao,et al.  Tissue-Type Plasminogen Activator and the Low-Density Lipoprotein Receptor-Related Protein Mediate Cerebral Ischemia-Induced Nuclear Factor-κB Pathway Activation , 2007 .

[12]  M. Chopp,et al.  Adjuvant Treatment With Neuroserpin Increases the Therapeutic Window for Tissue-Type Plasminogen Activator Administration in a Rat Model of Embolic Stroke , 2002, Circulation.

[13]  Z. Mao,et al.  Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation. , 2007, American Journal of Pathology.

[14]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[15]  Ulf Eriksson,et al.  Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke , 2008, Nature Medicine.

[16]  C. Fieber,et al.  Tissue plasminogen activator is a potent activator of PDGF‐CC , 2004, The EMBO journal.

[17]  P. Carmeliet,et al.  Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. , 1999, Circulation.

[18]  K. Bdeir,et al.  In vitro and in vivo effects of tPA and PAI-1 on blood vessel tone. , 2004, Blood.

[19]  D. Lawrence,et al.  Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. , 2003, The Journal of clinical investigation.

[20]  G. D. del Zoppo,et al.  Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. , 1994, The American journal of pathology.

[21]  Alain Buisson,et al.  The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling , 2001, Nature Medicine.

[22]  T. Davis,et al.  The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.

[23]  T. Sugawara,et al.  Delayed matrix metalloproteinase inhibition reduces intracerebral hemorrhage after embolic stroke in rats , 2008, Experimental Neurology.

[24]  K. Arai,et al.  Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator , 2003, Nature Medicine.

[25]  B. Rosen,et al.  Role of matrix metalloproteinases in delayed cortical responses after stroke , 2006, Nature Medicine.

[26]  S. Lipton,et al.  Tissue plasminogen activator (tPA) increase neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice , 1998, Nature Medicine.